Connection

BRYAN BURT to Carcinoma, Non-Small-Cell Lung

This is a "connection" page, showing publications BRYAN BURT has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength

4.840
  1. Commentary: The A, C, G, and Ts of differentiating stage I and stage IV lung cancer. J Thorac Cardiovasc Surg. 2020 08; 160(2):e83-e84.
    View in: PubMed
    Score: 0.487
  2. Commentary: Usurping the king: A step toward planning a biological checkmate on non-small cell lung carcinoma. J Thorac Cardiovasc Surg. 2019 09; 158(3):922-923.
    View in: PubMed
    Score: 0.466
  3. Commentary: Postoperative blood transplantation for non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019 06; 157(6):2480-2481.
    View in: PubMed
    Score: 0.455
  4. The importance of R0. J Thorac Cardiovasc Surg. 2018 01; 155(1):428-429.
    View in: PubMed
    Score: 0.423
  5. Programmed death ligand 1-associated antitumor immunity in early-stage non-small cell lung cancer: Expression of major histocompatibility complex I as a prerequisite. J Thorac Cardiovasc Surg. 2018 01; 155(1):393-394.
    View in: PubMed
    Score: 0.413
  6. Incompletely resected non-small cell lung cancer: Do we know how to handle a positive margin? J Thorac Cardiovasc Surg. 2017 08; 154(2):673-674.
    View in: PubMed
    Score: 0.402
  7. Overall Survival Following Thoracoscopic vs Open Lobectomy for Early-stage Non-small Cell Lung Cancer: A Meta-analysis. Semin Thorac Cardiovasc Surg. 2017 Spring; 29(1):104-112.
    View in: PubMed
    Score: 0.399
  8. Thoracoscopic lobectomy for clinical N2 and N1 lung cancer: Innovation outpacing standard of care. J Thorac Cardiovasc Surg. 2017 04; 153(4):977-978.
    View in: PubMed
    Score: 0.395
  9. Surgery versus SABR for resectable non-small-cell lung cancer. Lancet Oncol. 2015 Aug; 16(8):e372.
    View in: PubMed
    Score: 0.358
  10. A meta-analysis of resected metachronous second non-small cell lung cancer. Ann Thorac Surg. 2015 Apr; 99(4):1470-8.
    View in: PubMed
    Score: 0.347
  11. Improved detection of stage I non-small cell lung cancer with a serum-based assay. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):735-6.
    View in: PubMed
    Score: 0.342
  12. Transcriptome-based molecular subtyping of non-small cell lung cancer may predict response to immune checkpoint inhibitors. J Thorac Cardiovasc Surg. 2020 04; 159(4):1598-1610.e3.
    View in: PubMed
    Score: 0.120
  13. Matrix metalloproteinase 12 promotes tumor propagation in the lung. J Thorac Cardiovasc Surg. 2018 05; 155(5):2164-2175.e1.
    View in: PubMed
    Score: 0.107
  14. Early-stage non-small cell lung cancer: surgery, stereotactic radiosurgery, and individualized adjuvant therapy. Semin Oncol. 2014 Feb; 41(1):40-56.
    View in: PubMed
    Score: 0.080
  15. Diameter of non-small cell lung cancer correlates with long-term survival: implications for T stage. Chest. 2005 Nov; 128(5):3255-60.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.